Analysis of the Global Market Development for Peripheral Vascular Devices

With the intensifying global population aging and the rising incidence of chronic diseases, the demand for the treatment of Peripheral Vascular Diseases (PVD) is continually growing. As a crucial part of the medical technology field, the peripheral vascular devices market is experiencing rapid development opportunities.

Market Segmentation and Key Product Types

The peripheral vascular devices market can be segmented into several sub-markets based on product types, with key product types including:

Angioplasty Stents

It is estimated that by 2029, the angioplasty stent market will reach $3.635 billion, with a compound annual growth rate (CAGR) of 3.8%. Among them, drug-eluting stents dominate due to their lower restenosis rates. These stents are being increasingly used in the treatment of peripheral arterial diseases.

Endovascular Aneurysm Repair (EVAR) Stent Grafts
This market is expected to reach $3.078 billion by 2029, with a CAGR of 6.3%. Abdominal Aortic Aneurysm (AAA) stent grafts held 81.4% of the EVAR stent graft market in 2023. These stents play a significant role in treating diseases such as aortic aneurysms.

Catheters

The catheter market is expected to reach $1.564 billion by 2029, with a CAGR of 5.7%. Among them, angiographic catheters held 45.6% of the catheter market in 2023. Angiographic catheters are indispensable tools in diagnosing and treating vascular diseases.

Inferior Vena Cava Filters

By 2029, the inferior vena cava filter market is expected to reach $1.559 billion, with a CAGR of 6.0%. Retrievable filters dominate this market due to their lower long-term risk and ease of removal.

Thrombectomy Devices

The thrombectomy devices market is expected to reach $869 million by 2029, with a CAGR of 6.4%. Among them, atherectomy accounted for 64.9% of the thrombectomy devices market in 2024. These devices play a crucial role in treating thrombosis and atherosclerosis.

Regional Market Analysis

North American Market

In the North American region, particularly the United States, the peripheral vascular devices market held the largest share in 2023 and is expected to retain its leading position until 2029. The innovation in medical technology, a higher proportion of the elderly population, and increased healthcare spending in the United States all provide robust support for market growth.

Asia-Pacific Market

The Asia-Pacific region is expected to achieve the highest CAGR of 7.2% during the forecast period. This growth is mainly attributed to the increase in the elderly population, improved awareness of peripheral arterial diseases, and increased healthcare spending in the region. Countries such as China, India, Japan, and South Korea have huge market potential and are expected to become significant growth points in the peripheral vascular devices market.

European Market

The European market holds an important position in the global peripheral vascular devices market. The development of medical technology in some European countries is relatively mature, and the aging population issue is becoming more serious, leading to a continuous increase in the demand for peripheral vascular devices. The European market is expected to continue growing steadily until 2029.

Latin American and Middle Eastern & African Markets

Although the Latin American and Middle Eastern & African markets are relatively small, with economic development and advancements in medical technology, these regions also show potential for growth in the application of peripheral vascular devices. Especially in the Middle East and Africa, with increased medical investments, the peripheral vascular devices market is expected to achieve rapid growth in the coming years.

The global peripheral vascular interventional devices market will continue to maintain strong growth in the coming years. With the aging population, prevalence of chronic diseases, technological advances, and the popularization of minimally invasive surgeries, peripheral vascular devices will play an increasingly important role in the treatment of peripheral vascular diseases. For market participants, seizing opportunities in emerging markets, strengthening technological innovation, and improving product quality and service levels will be key to future development.